Structure-based, rational design of T cell receptors

Frontiers in Immunology

Volumn 4, Issue SEP, 2013, Pages

  Zoete, V ^a   Irving, M ^a,b   Ferber, M ^a   Cuendet, M A ^a,c   Michielin, O ^a,b,d  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b Centre du cancer de Lausanne   (Switzerland)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Adoptive transfer; Cancer; Immunotherapy; Molecular modeling; Protein engineering; TCR; TCR pMHC

Indexed keywords

EID: 84886003861     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00268     Document Type: Review

References (135)

1. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 24:419-66. doi:10.1146/annurev.immunol.23.021704.115658.
2. Burrows SR, Chen Z, Archbold JK, Tynan FE, Beddoe T, Kjer-Nielsen L, et al. Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci U S A (2010) 107:10608-13. doi:10.1073/pnas.1004926107.
3. Garcia KC, Adams EJ. How the T cell receptor sees antigen-a structural view. Cell (2005) 122:333-6. doi:10.1016/j.cell.2005.07.015.
4. Godfrey DI, Rossjohn J, McCluskey J. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition. Immunity (2008) 28:304-14. doi:10.1016/j.immuni.2008.02.004.
5. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, et al. Ligand recognition by alpha beta T cell receptors. Annu Rev Immunol (1998) 16:523-44. doi:10.1146/annurev.immunol.16.1.523.
6. Dietrich P-Y, Le Gal F-A, Dutoit V, Pittet MJ, Trautman L, Zippelius A, et al. Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen. J Immunol (2003) 170:5103-9.
7. Irving M, Zoete V, Hebeisen M, Schmid D, Baumgartner P, Guillaume P, et al. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness. J Biol Chem (2012) 287:23068-78. doi:10.1074/jbc. M112.357673.
8. Schmid DA, Irving MB, Posevitz V, Hebeisen M, Posevitz-Fejfar A, Sarria J-CF, et al. Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function. J Immunol (2010) 184:4936-46. doi:10.4049/jimmunol.1000173.
9. Valmori D, Dutoit V, Schnuriger V, Quiquerez A-L, Pittet MJ, Guillaume P, et al. Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. J Immunol (2002) 168:4231-40.
10. Krogsgaard M, Davis MM. How T cells "see" antigen. Nat Immunol (2005) 6:239-45. doi:10.1038/ni1173.
11. Stone JD, Chervin AS, Kranz DM. T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity. Immunology (2009) 126:165-76. doi:10.1111/j.1365-2567.2008.03015.x.
12. Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol (2012) 12:269-81. doi:10.1038/nri3191.
13. Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer (2008) 8:299-308. doi:10.1038/nrc2355.
14. Khan JM, Cheruku HR, Tong JC, Ranganathan S. MPID-T2: a database for sequence-structure-function analyses of pMHC and TR/pMHC structures. Bioinformatics (2011) 27:1192-3. doi:10.1093/bioinformatics/btr104.
15. Gras S, Burrows SR, Turner SJ, Sewell AK, McCluskey J, Rossjohn J. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Immunol Rev (2012) 250:61-81. doi:10.1111/j.1600-065X.2012.01159.x.
16. Wang J-H, Reinherz EL. The structural basis of aβ T-lineage immune recognition: TCR docking topologies, mechanotransduction, and co-receptor function. Immunol Rev (2012) 250:102-19. doi:10.1111/j.1600-065X.2012.01161.x.
17. Armstrong KM, Insaidoo FK, Baker BM. Thermodynamics of T-cell receptor-peptide/MHC interactions: progress and opportunities. J Mol Recognit (2008) 21:275-87. doi:10.1002/jmr.896.
18. Ding YH, Baker BM, Garboczi DN, Biddison WE. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity (1999) 11:45. doi:10.1016/S1074-7613(00)80080-1.
19. Davis-Harrison RL, Armstrong KM, Baker BM. Two different T cell receptors use different thermodynamic strategies to recognize the same peptide/MHC ligand. J Mol Biol (2005) 346:533-50. doi:10.1016/j.jmb.2004.11.063.
20. Cuendet MA, Zoete V, Michielin O. How T cell receptors interact with peptide-MHCs: a multiple steered molecular dynamics study. Proteins (2011) 79:3007-24. doi:10.1002/prot.23104.
21. Lindahl E, Hess B, van der Spoel D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Mod (2001) 7:306.
22. Daura X, Mark AE, van Gunsteren WF. Parametrization of aliphatic CHn united atoms of GROMOS96 force field. J Comput Chem (1998) 19:535-47. doi:10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N.
23. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature (2002) 418:552-6. doi:10.1038/nature00920.
24. Gagnon SJ, Borbulevych OY, Davis-Harrison RL, Baxter TK, Clemens JR, Armstrong KM, et al. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants. J Mol Biol (2005) 353:556-73. doi:10.1016/j.jmb.2005.08.024.
25. Boudinot P, Marriotti-Ferrandiz ME, Pasquier LD, Benmansour A, Cazenave P-A, Six A. New perspectives for large-scale repertoire analysis of immune receptors. Mol Immunol (2008) 45:2437-45. doi:10.1016/j.molimm.2007.12.018.
26. Derré L, Bruyninx M, Baumgaertner P, Ferber M, Schmid D, Leimgruber A, et al. Distinct sets of alphabeta TCRs confer similar recognition of tumor antigen NY-ESO-1157-165 by interacting with its central Met/Trp residues. Proc Natl Acad Sci U S A (2008) 105:15010-5. doi:10.1073/pnas.0807954105.
27. Romero P, Dunbar PR, Valmori D, Pittet M, Ogg GS, Rimoldi D, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med (1998) 188:1641-50. doi:10.1084/jem.188.9.1641.
28. Leimgruber A, Ferber M, Irving M, Hussain-Kahn H, Wieckowski S, Derré L, et al. TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires. PLoS ONE (2011) 6:e26301. doi:10.1371/journal.pone.0026301.
29. Michielin O, Luescher I, Karplus M. Modeling of the TCR-MHC-peptide complex. J Mol Biol (2000) 300:1205-35. doi:10.1006/jmbi.2000.3788.
30. Zoete V, Irving MB, Michielin O. MM-GBSA binding free energy decomposition and T cell receptor engineering. J Mol Recognit (2010) 23:142-52. doi:10.1002/jmr.1005.
31. Ehrenmann F, Lefranc M-P. IMGT/3D structure-DB: querying the IMGT database for 3D structures in immunology and immunoinformatics (IG or antibodies, TR, MH, RPI, and FPIA). Cold Spring Harb Protoc (2011) 2011:750-61. doi:10.1101/pdb.prot5637.
32. Ehrenmann F, Kaas Q, Lefranc M-P. IMGT/3D structure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF. Nucleic Acids Res (2010) 38:D301-7. doi:10.1093/nar/gkp946.
33. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 286:958-61. doi:10.1126/science.286.5441.958.
34. Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood (2009) 114:4099-107. doi:10.1182/blood-2009-04-217604.
35. Kessler B, Michielin O, Blanchard CL, Apostolou I, Delarbre C, Gachelin G, et al. T cell recognition of hapten. Anatomy of T cell receptor binding of a H-2kd-associated photoreactive peptide derivative. J Biol Chem (1999) 274:3622-31. doi:10.1074/jbc.274.6.3622.
36. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen M-Y, et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics (2006) 5:Unit5.6.
37. Martí-Renom MA, Stuart AC, Fiser A, Sánchez R, Melo F, Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct (2000) 29:291-325. doi:10.1146/annurev.biophys.29.1.291.
38. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 234:779-815. doi:10.1006/jmbi.1993.1626.
39. Bentley GA, Boulot G, Karjalainen K, Mariuzza RA. Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 267:1984-7. doi:10.1126/science.7701320.
40. Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, et al. Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 270:1821-4. doi:10.1126/science.270.5243.1821.
41. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature (1996) 384:134-41. doi:10.1038/384134a0.
42. Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science (1998) 279:1166-72. doi:10.1126/science.279.5354.1166.
43. Fremont DH, Stura EA, Matsumura M, Peterson PA, Wilson IA. Crystal structure of an H-2Kb-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc Natl Acad Sci U S A (1995) 92:2479-83. doi:10.1073/pnas.92.7.2479.
44. Fiser A, Do RK, Sali A. Modeling of loops in protein structures. Protein Sci (2000) 9:1753-73. doi:10.1110/ps.9.9.1753.
45. Fagerberg T, Cerottini J-C, Michielin O. Structural prediction of peptides bound to MHC class I. J Mol Biol (2006) 356:521-46. doi:10.1016/j.jmb.2005.11.059.
46. Al-Lazikani B, Lesk AM, Chothia C. Canonical structures for the hypervariable regions of T cell alphabeta receptors. J Mol Biol (2000) 295:979-95. doi:10.1006/jmbi.1999.3358.
47. Derré L, Ferber M, Touvrey C, Devevre E, Zoete V, Leimgruber A, et al. A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide. J Immunol (2007) 179:7635-45.
48. Khan JM, Ranganathan S. Understanding TR binding to pMHC complexes: how does a TR scan many pMHC complexes yet preferentially bind to one. PLoS ONE (2011) 6:e17194. doi:10.1371/journal.pone.0017194.
49. Roomp K, Domingues FS. Predicting interactions between T cell receptors and MHC-peptide complexes. Mol Immunol (2011) 48:553-62. doi:10.1016/j.molimm.2010.10.014.
50. Varani L, Bankovich AJ, Liu CW, Colf LA, Jones LL, Kranz DM, et al. Solution mapping of T cell receptor docking footprints on peptide-MHC. Proc Natl Acad Sci U S A (2007) 104:13080-5. doi:10.1073/pnas.0703702104.
51. Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B, et al. CHARMM: the biomolecular simulation program. J Comput Chem (2009) 30:1545-614. doi:10.1002/jcc.21287.
52. Mackerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 102:3586-616. doi:10.1021/jp973084f.
53. Haberthür U, Caflisch A. FACTS: fast analytical continuum treatment of solvation. J Comput Chem (2008) 29:701-15. doi:10.1002/jcc.20832.
54. Zoete V, Meuwly M, Karplus M. Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition. Proteins (2005) 61:79-93. doi:10.1002/prot.20528.
55. Ferber M, Zoete V, Michielin O. T-cell receptors binding orientation over peptide/MHC class I is driven by long-range interactions. PLoS ONE (2012) 7:e51943. doi:10.1371/journal.pone.0051943.
56. Baker BM, Gagnon SJ, Biddison WE, Wiley DC. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling. Immunity (2000) 13:475-84. doi:10.1016/S1074-7613(00)00047-9.
57. Michielin O, Karplus M. Binding free energy differences in a TCR-peptide-MHC complex induced by a peptide mutation: a simulation analysis. J Mol Biol (2002) 324:547-69. doi:10.1016/S0022-2836(02)00880-X.
58. Christ CD, Mark AE, van Gunsteren WF. Basic ingredients of free energy calculations: a review. J Comput Chem (2010) 31:1569-82. doi:10.1002/jcc.21450.
59. Cuendet MA, Zoete V, Michielin O. Molecular Dynamics-based Free Energy Simulations. In: Schwede T, Peitsch M editors. Computational Structural Biology. Singapore: World Scientific Publishing (2008). p. 513-48.
60. Gao J, Kuczera K, Tidor B, Karplus M. Hidden thermodynamics of mutant proteins: a molecular dynamics analysis. Science (1989) 244:1069-72. doi:10.1126/science.2727695.
61. Kirkwood JG. Statistical mechanics of fluid mixture. J Chem Phys (1935) 3:300-13. doi:10.1063/1.1749657.
62. Boresch S, Karplus M. The role of bonded terms in free energy simulations: 1. Theoretical analysis. J Phys Chem A (2013) 103:103-18. doi:10.1021/jp981628n.
63. Beutler TC, Mark AE, van Schaik RC, Gerber PB, van Gunsteren WF. Avoiding singularities and numerical instabilities in free energy calculations based on molecular simulations. Chem Phys Lett (1994) 222:529-39. doi:10.1016/0009-2614(94)00397-1.
64. Madden DR, Garboczi DN, Wiley DC. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell (1993) 75:693-708. doi:10.1016/0092-8674(93)90490-H.
65. Brooks CL, Brünger A, Karplus M. Active site dynamics in protein molecules: a stochastic boundary molecular-dynamics approach. Biopolymers (1985) 24:843-65. doi:10.1002/bip.360240509.
66. Jarzynski C. A non-equilibrium equality for free energy differences. Phys Rev Lett (1997) 78:2690-3. doi:10.1103/PhysRevLett.78.2690.
67. Jarzynski C. Equilibrium free energy differences from non-equilibrium measurements: a master equation approach. Phys Rev E (1997) 56:5018-35. doi:10.1103/PhysRevE.56.5018.
68. Cuendet MA. Statistical mechanical derivation of Jarzynski's identity for thermostated non-Hamiltonian dynamics. Phys Rev Lett (2006) 96:120602. doi:10.1103/PhysRevLett.96.120602.
69. Cuendet MA. The Jarzynski identity derived from general Hamiltonian or non-Hamiltonian dynamics reproducing NVT or NPT ensembles. J Chem Phys (2006) 125:144109-144109-12. doi:10.1063/1.2338535.
70. Isralewitz B, Davis-Harrison RL, Baudry J, Armstrong KM, Gullingsrud J, Baker BM, et al. Steered molecular dynamics investigations of protein function. J Mol Graphics Modell (2001) 19:13. doi:10.1016/S1093-3263(00)00133-9.
71. Park S, Schulten K. Calculating potentials of mean force from steered molecular dynamics information. J Chem Phys (2004) 120:5946-61. doi:10.1063/1.1651473.
72. Cuendet MA, Michielin O. Protein-protein interaction investigated by steered molecular dynamics: the TCR-pMHC complex. Biophys J (2008) 95:3575-90. doi:10.1529/biophysj.108.131383.
73. Hummer G, Szabo A. Free energy reconstruction from non-equilibrium single-molecule pulling experiments. Proc Natl Acad Sci U S A (2001) 98:3658-61. doi:10.1073/pnas.071034098.
74. Schurr JM, Fujimoto BS. Equalities for the non-equilibrium work transferred from an external potential to a molecular system. analysis of single-molecule extension experiments. J Phys Chem B (2003) 107:14007-19. doi:10.1021/jp0306803.
75. Hendrix DA, Jarzynski C. A "fast growth" method of computing free energy differences. J Chem Phys (2001) 114:5974. doi:10.1063/1.1353552.
76. Oberhofer H, Dellago C, Geissler PL. Biased sampling of non-equilibrium trajectories: can fast switching simulations outperform conventional free energy calculation methods? J Phys Chem B (2005) 109:6902-15. doi:10.1021/jp044556a.
77. Rudolph MG, Zuckerman DM, Stanfield RL, Woolf TB, Wilson IA. Systematic finite-sampling inaccuracy in free energy differences and other non-linear quantities. J Stat Phys (2004) 114:1303. doi:10.1023/B:JOSS.0000013961.84860.5b.
78. Shirts MR, Pande VS. Comparison of efficiency and bias of free energies computed by exponential averaging, the Bennett acceptance ratio, and thermodynamic integration. J Chem Phys (2005) 122:144107. doi:10.1063/1.1873592.
79. Ytreberg FM, Swendsen RH, Zuckerman DM. Comparison of free energy methods for molecular systems. J Chem Phys (2006) 125:184114. doi:10.1063/1.2378907.
80. Kollman PA, Massova I, Reyes C, Kuhn B, Huo S, Chong L, et al. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 33:889-97. doi:10.1021/ar000033j.
81. Gilson MK, Honig B. Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis. Proteins (1988) 4:7-18. doi:10.1002/prot.340040104.
82. Gilson MK, Honig BH. Energetics of charge-charge interactions in proteins. Proteins (1988) 3:32-52. doi:10.1002/prot.340030104.
83. Still WC, Tempczyk A, Hawley RC, Hendrickson T. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc (1990) 112:6127-9. doi:10.1021/ja00172a038.
84. Gohlke H, Kiel C, Case DA. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. J Mol Biol (2003) 330:891-913. doi:10.1016/S0022-2836(03)00610-7.
85. Amidon GL, Yalkowsky SH, Anik ST, Valvani SC. Solubility of non-electrolytes in polar solvents. V. Estimation of the solubility of aliphatic monofunctional compounds in water using a molecular surface area approach. J Phys Chem (2013) 79:2239-46. doi:10.1021/j100588a008.
86. Tidor B, Karplus M. The contribution of vibrational entropy to molecular association. The dimerization of insulin. J Mol Biol (1994) 238:405-14. doi:10.1006/jmbi.1994.1300.
87. Guo J, Wang X, Sun H, Liu H, Yao X. The molecular basis of IGF-II/IGF2R recognition: a combined molecular dynamics simulation, free-energy calculation and computational alanine scanning study. J Mol Model (2012) 18:1421-30. doi:10.1007/s00894-011-1159-4.
88. Lafont V, Schaefer M, Stote RH, Altschuh D, Dejaegere A. Protein-protein recognition and interaction hot spots in an antigen-antibody complex: free energy decomposition identifies "efficient amino acids." Proteins (2007) 67:418-34. doi:10.1002/prot.21259.
89. Oberlin M, Kroemer R, Mikol V, Minoux H, Tastan E, Baurin N. Engineering protein therapeutics: predictive performances of a structure-based virtual affinity maturation protocol. J Chem Inf Model (2012) 52:2204-14. doi:10.1021/ci3001474.
90. Zoete V, Michielin O. Comparison between computational alanine scanning and per-residue binding free energy decomposition for protein-protein association using MM-GBSA: application to the TCR-p-MHC complex. Proteins (2007) 67:1026-47. doi:10.1002/prot.21395.
91. Massova I, Kollman PA. Computational alanine scanning to probe protein-protein interactions: a novel approach to evaluate binding free energies. J Am Chem Soc (1999) 121:8133-43. doi:10.1021/ja990935j.
92. Degano M, Garcia KC, Apostolopoulos V, Rudolph MG, Teyton L, Wilson IA. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity (2000) 12:251-61. doi:10.1016/S1074-7613(00)80178-8.
93. Richman SA, Kranz DM. Display, engineering, and applications of antigen-specific T cell receptors. Biomol Eng (2007) 24:361-73. doi:10.1016/j.bioeng.2007.02.009.
94. Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, et al. Human TCR-binding affinity is governed by MHC class restriction. J Immunol (2007) 178:5727-34.
95. Johnson LA, Morgan RA, Dudley ME, Cassard L, Yang JC, Hughes MS, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood (2009) 114:535-46. doi:10.1182/blood-2009-03-211714.
96. Kalergis AM, Boucheron N, Doucey MA, Palmieri E, Goyarts EC, Vegh Z, et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol (2001) 2:229-34. doi:10.1038/85286.
97. Valitutti S. The serial engagement model 17-years after: from tcr triggering to immunotherapy. Front Immunol (2012) 3:272. doi:10.3389/fimmu.2012.00272.
98. Aleksic M, Dushek O, Zhang H, Shenderov E, Chen J-L, Cerundolo V, et al. Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time. Immunity (2010) 32:163-74. doi:10.1016/j.immuni.2009.11.013.
99. Chlewicki LK, Holler PD, Monti BC, Clutter MR, Kranz DM. High-affinity, peptide-specific T cell receptors can be generated by mutations in CDR1, CDR2 or CDR3. J Mol Biol (2005) 346:223-39. doi:10.1016/j.jmb.2004.11.057.
100. Holler PD, Holman PO, Shusta EV, O'Herrin S, Wittrup KD, Kranz DM. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc Natl Acad Sci U S A (2000) 97:5387-92. doi:10.1073/pnas.080078297.
101. Holler PD, Kranz DM. Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. Immunity (2003) 18:255-64. doi:10.1016/S1074-7613(03)00019-0.
102. Li Y, Moysey R, Molloy PE, Vuidepot A-L, Mahon T, Baston E, et al. Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat Biotechnol (2005) 23:349-54. doi:10.1038/nbt1070.
103. Dunn SM, Rizkallah PJ, Baston E, Mahon T, Cameron B, Moysey R, et al. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Sci (2006) 15:710-21. doi:10.1110/ps.051936406.
104. Bowerman NA, Crofts TS, Chlewicki L, Do P, Baker BM, Christopher Garcia K, et al. Engineering the binding properties of the T cell receptor:peptide:MHC ternary complex that governs T cell activity. Mol Immunol (2009) 46:3000-8. doi:10.1016/j.molimm.2009.06.012.
105. Buonpane RA, Moza B, Sundberg EJ, Kranz DM. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1. J Mol Biol (2005) 353:308-21. doi:10.1016/j.jmb.2005.08.041.
106. Kieke MC, Sundberg E, Shusta EV, Mariuzza RA, Wittrup KD, Kranz DM. High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol (2001) 307:1305-15. doi:10.1006/jmbi.2001.4560.
107. Zhao Y, Bennett AD, Zheng Z, Wang QJ, Robbins PF, Yu LYL, et al. High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines. J Immunol (2007) 179:5845-54.
108. Chervin AS, Aggen DH, Raseman JM, Kranz DM. Engineering higher affinity T cell receptors using a T cell display system. J Immunol Methods (2008) 339:175-84. doi:10.1016/j.jim.2008.09.016.
109. Kessels HW, van Den Boom MD, Spits H, Hooijberg E, Schumacher TN. Changing T cell specificity by retroviral T cell receptor display. Proc Natl Acad Sci U S A (2000) 97:14578-83. doi:10.1073/pnas.97.26.14578.
110. Hawkins RE, Gilham DE, Debets R, Eshhar Z, Taylor N, Abken H, et al. Development of adoptive cell therapy for cancer: a clinical perspective. Hum Gene Ther (2010) 21:665-72. doi:10.1089/hum.2010.086.
111. Barrozo A, Borstnar R, Marloie G, Kamerlin SCL. Computational protein engineering: bridging the gap between rational design and laboratory evolution. Int J Mol Sci (2012) 13:12428-60. doi:10.3390/ijms131012428.
112. Karanicolas J, Kuhlman B. Computational design of affinity and specificity at protein-protein interfaces. Curr Opin Struct Biol (2009) 19:458-63. doi:10.1016/j.sbi.2009.07.005.
113. Pantazes RJ, Maranas CD. OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding. Protein Eng Des Sel (2010) 23:849-58. doi:10.1093/protein/gzq061.
114. Pantazes RJ, Grisewood MJ, Maranas CD. Recent advances in computational protein design. Curr Opin Struct Biol (2011) 21:467-72. doi:10.1016/j.sbi.2011.04.005.
115. Samish I, MacDermaid CM, Perez-Aguilar JM, Saven JG. Theoretical and computational protein design. Annu Rev Phys Chem (2011) 62:129-49. doi:10.1146/annurev-physchem-032210-103509.
116. Haidar JN, Pierce B, Yu Y, Tong W, Li M, Weng Z. Structure-based design of a T-cell receptor leads to nearly 100-fold improvement in binding affinity for pepMHC. Proteins (2009) 74:948-60. doi:10.1002/prot.22203.
117. Le Gal F-A, Ayyoub M, Dutoit V, Widmer V, Jäger E, Cerottini J-C, et al. Distinct structural TCR repertoires in naturally occurring versus vaccine-induced CD8+ T-cell responses to the tumor-specific antigen NY-ESO-1. J Immunother (2005) 28:252-7. doi:10.1097/01.cji.0000161398.34701.26.
118. Atanackovic D, Arfsten J, Cao Y, Gnjatic S, Schnieders F, Bartels K, et al. Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation. Blood (2007) 109:1103-12. doi:10.1182/blood-2006-04-014480.
119. Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A (1997) 94:1914-8. doi:10.1073/pnas.94.5.1914.
120. Liggins AP, Lim SH, Soilleux EJ, Pulford K, Banham AH. A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies. Cancer Immun (2010) 10:8.
121. Lim SH, Austin S, Owen-Jones E, Robinson L. Expression of testicular genes in haematological malignancies. Br J Cancer (1999) 81:1162-4. doi:10.1038/sj.bjc.6690824.
122. Marsh S, Parham P, Barber LD. The HLA Factsbook. (1999).
123. Yuan J, Adamow M, Ginsberg BA, Rasalan TS, Ritter E, Gallardo HF, et al. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc Natl Acad Sci U S A (2011) 108:16723-8. doi:10.1073/pnas.1110814108.
124. Chen J-L, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, Choi EML, et al. Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J Exp Med (2005) 201:1243-55. doi:10.1084/jem.20042323.
125. Rose PW, Bi C, Bluhm WF, Christie CH, Dimitropoulos D, Dutta S, et al. The RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res (2013) 41:D475-82. doi:10.1093/nar/gks1200.
126. Sami M, Rizkallah PJ, Dunn S, Molloy P, Moysey R, Vuidepot A, et al. Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. Protein Eng Des Sel (2007) 20:397-403. doi:10.1093/protein/gzm033.
127. Hubbard RE, Haider MK. Hydrogen bonds in proteins: role and strength. Encyclopedia of Life Science (2001). 1-6.
128. Chang HC, Bao Z, Yao Y, Tse AG, Goyarts EC, Madsen M, et al. A general method for facilitating heterodimeric pairing between two proteins: application to expression of alpha and beta T-cell receptor extracellular segments. Proc Natl Acad Sci U S A (1994) 91:11408-12. doi:10.1073/pnas.91.24.11408.
129. Boulter JM, Glick M, Todorov PT, Baston E, Sami M, Rizkallah P, et al. Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng (2003) 16:707-11. doi:10.1093/protein/gzg087.
130. Janin J. The kinetics of protein-protein recognition. Proteins (1997) 28:153-61. doi:10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G.
131. Tian S, Maile R, Collins EJ, Frelinger JA. CD8+ T cell activation is governed by TCR-peptide/MHC affinity, not dissociation rate. J Immunol (2007) 179:2952-60.
132. Kersh EN, Shaw AS, Allen PM. Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. Science (1998) 281:572-5. doi:10.1126/science.281.5376.572.
133. McKeithan TW. Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci U S A (1995) 92:5042-6. doi:10.1073/pnas.92.11.5042.
134. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (1995) 375:148-51. doi:10.1038/375148a0.
135. Dushek O, Aleksic M, Wheeler RJ, Zhang H, Cordoba S-P, Peng Y-C, et al. Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. Sci Signal (2011) 4:ra39. doi:10.1126/scisignal.2001430.